(19)

(11)

EP 4 076 483 A1

(12)

(43) Date of publication: 26.10.2022 Bulletin 2022/43 (21) Application number: 20838484.2 (22) Date of filing: 18.12.2020

(51) International Patent Classification (IPC):  A61K 35/74(2015.01) A61K 9/19(2006.01) A61P 25/18(2006.01) A61P 25/28(2006.01) A61K 9/00(2006.01) A61P 25/00(2006.01) A61P 25/24(2006.01) (52) Cooperative Patent Classification (CPC): A61K 35/74; A61K 9/0053; A61K 9/19; A61P 25/00; A61P 25/24; A61P 25/18; A61P 25/28; A61K 35/742; Y02A 50/30 (86) International application number: PCT/EP2020/087317 (87) International publication number: WO 2021/123378 (24.06.2021 Gazette 2021/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 20.12.2019 EP 19219112 (71) Applicant: 4D Pharma Research Limited Aberdeen, Aberdeenshire AB25 2ZS (GB)	(72) Inventors: MULDER, Imke Elisabeth Aberdeen AB25 2ZS (GB) REICHARDT, Nicole Aberdeen AB25 2ZS (GB) SAVIGNAC, Helene Aberdeen AB25 2ZS (GB) CHETAL, Sasha Aberdeen AB25 2ZS (GB) DINAN, Ted Cobh, County Cork (IE) CRYAN, John Cork (IE) (74) Representative: Brand Murray Fuller LLP  50 Eastcastle Street London W1W 8EA London W1W 8EA (GB)